Explore how quinoxaline chemistry is creating innovative anticancer agents through strategic molecular design and synthesis.
Explore the molecular pharmacology and antitumor activity of PHT-427, a novel dual-targeting inhibitor of Akt and PDPK1 with promising cancer therapeutic potential.
Discover how palmitoylation, a tiny molecular tag, rewires prostate cancer metabolism and fuels disease progression through androgen signaling.
Discover how proton magnetic resonance spectroscopy revolutionizes breast cancer diagnosis with over 95% accuracy by detecting cancer's unique chemical fingerprints.
Discover how X-ray crystallography reveals atomic-level DNA damage from oxidative stress and the cellular defense mechanisms that protect our genetic code.
Discover how a revolutionary fluorescence-based assay is accelerating the discovery of DNA-binding drugs for cancer and genetic diseases.
Explore how lipid-coated mesoporous silica nanoparticles with large pores enable dual cargo delivery for advanced cancer treatment through nanotechnology.
Explore how hypoxic breast cancer cells reprogram glycolytic shunt pathways to survive low oxygen conditions and become more aggressive.
Explore ARX517, a novel antibody-drug conjugate showing promise in treating metastatic castration-resistant prostate cancer through targeted PSMA therapy.
Exploring how PV-10 cancer immunotherapy causes cherry-red plasma and interferes with laboratory tests while activating anti-tumor immunity.